A Study of Initial Therapy for Glaucoma in Southern India: India Glaucoma Outcomes and Treatment (INGOT) Study

Purpose: To compare initial glaucoma therapy with medications and trabeculectomy in southern India. Methods: Patients aged ≥30 years newly diagnosed with glaucoma were randomized to trabeculectomy with 5-fluorouracil or medical therapy. Subjects with best-corrected vision <6/18 due to cataract underwent phacoemulsification (phaco/intraocular lens, IOL). Intraocular pressure (IOP), vision and visual function were assessed at 12 months. Results: Patients assigned to medications and surgery received the expected therapy in 86% (172/199) and 64% (126/199) of cases, respectively. Forty patients (20%) assigned to surgery refused any treatment and 33 (17%) received medications. Among 199 patients randomized to medications, 52 (26.1%) underwent phaco/IOL, as did 89/199 (43.7%) of patients randomized to trabeculectomy. Baseline parameters of the two groups did not differ, nor did 1-year follow-up rates (medication 65%, trabeculectomy 58%, P = 0.15). Final IOP was lower with randomization to trabeculectomy (16.3 ± 5.1 mmHg) than medication (18.8 ± 6.7 mmHg, P < 0.0001). In regression models, randomization to trabeculectomy (P < 0.0001) was associated with lower IOP, and simultaneous trabeculectomy and cataract surgery was associated with higher IOP (P = 0.008) than trabeculectomy alone. Subjects receiving Phaco/IOL had significantly better final acuity (P < 0.0001) and visual function (P = 0.035), despite concurrent glaucoma treatment. Final visual acuity was worse in those receiving trabeculectomy in addition to cataract surgery, but this was of borderline significance (P = 0.06). Conclusions: Trabeculectomy lowered IOP significantly more than medical treatment, but with slightly greater loss of visual acuity. Combined phaco/IOL and trabeculectomy improved visual acuity with substantial IOP lowering.

[1]  Rajat D Maheshwari,et al.  Phacotrabeculectomy Without Mitomycin C in Primary Angle-closure and Open-angle Glaucoma , 2011, Journal of glaucoma.

[2]  Douglas G Altman,et al.  The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study , 2009, BMJ : British Medical Journal.

[3]  D. Friedman,et al.  Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma. , 2009, Ophthalmology.

[4]  Praveen Vashist,et al.  Current status of cataract blindness and Vision 2020: The right to sight initiative in India , 2008, Indian journal of ophthalmology.

[5]  C. McCarty,et al.  Prevalence of primary open-angle glaucoma in an urban south Indian population and comparison with a rural population. The Chennai Glaucoma Study. , 2008, Ophthalmology.

[6]  Haynes Rb,et al.  Interventions for enhancing medication adherence (Review) , 2008 .

[7]  A. Ndiaye,et al.  Effectiveness of a strategy to improve adherence to tuberculosis treatment in a resource-poor setting: a cluster randomized controlled trial. , 2007, JAMA.

[8]  C. McCarty,et al.  Glaucoma in aphakia and pseudophakia in the Chennai Glaucoma Study , 2005, British Journal of Ophthalmology.

[9]  G. Rao,et al.  Present status of eye care in India. , 2005, Survey of ophthalmology.

[10]  Ravi Thomas,et al.  Glaucoma management in developing countries: medical, laser, and surgical options for glaucoma management in countries with limited resources , 2004, Current opinion in ophthalmology.

[11]  R. Sihota,et al.  Long‐term evaluation of trabeculectomy in primary open angle glaucoma and chronic primary angle closure glaucoma in an Asian population , 2004, Clinical & experimental ophthalmology.

[12]  J. Katz,et al.  Blindness and vision impairment in a rural south Indian population: the Aravind Comprehensive Eye Survey. , 2003, Ophthalmology.

[13]  Alan L Robin,et al.  Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey. , 2003, Ophthalmology.

[14]  N. Congdon,et al.  Surgical strategies for coexisting glaucoma and cataract: an evidence-based update. , 2002, Ophthalmology.

[15]  R. Sihota,et al.  Assessing the role of subconjunctival versus intrascleral application of mitomycin C in high-risk trabeculectomies. , 2001, Indian Journal of Ophthalmology.

[16]  L. Dandona,et al.  Blindness in the Indian state of Andhra Pradesh. , 2001, Investigative ophthalmology & visual science.

[17]  L. Dandona,et al.  Open-angle glaucoma in an urban population in southern India: the Andhra Pradesh eye disease study. , 2000, Ophthalmology.

[18]  B. Prum,et al.  The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deterioration , 2000 .

[19]  L. Vijaya,et al.  Comparison of low-dose intraoperative mitomycin-C vs 5-fluorouracil in primary glaucoma surgery: a pilot study. , 2000, Ophthalmic surgery and lasers.

[20]  A. Robin,et al.  A long-term dose-response study of mitomycin in glaucoma filtration surgery. , 1997, Archives of ophthalmology.

[21]  L B Ellwein,et al.  Measurements of vision function and quality of life in patients with cataracts in southern India. Report of instrument development. , 1997, Archives of ophthalmology.

[22]  J. Avorn,et al.  Treatment for glaucoma: adherence by the elderly. , 1993, American journal of public health.

[23]  H. Jampel,et al.  Intraocular pressure reduction in normal-tension glaucoma patients. The Normal Tension Glaucoma Study Group. , 1992, Ophthalmology.